Oncogenic Role of the Ubiquitin Ligase Subunit Skp2 in Human Breast Cancer

Journal of Clinical Investigation - United States
doi 10.1172/jci90690
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Pathogenic Role of the CRL4 Ubiquitin Ligase in Human Disease

Frontiers in Oncology
Cancer ResearchOncology
2012English

BRCC36, a Novel Subunit of a BRCA1/2 E3 Ubiquitin Ligase Complex: Candidate Breast Cancer Susceptibility Gene

2004English

The Oncogenic Role of RhoGAPs in Basal-Like Breast Cancer

2015English

siRNA KNOCKDOWN SKP2 GENE IN BREAST CANCER

The Egyptian Journal of Biochemistry and Molecular Biology
2016English

The Deubiquitinase USP9X Regulates the Stability and Function of E3 Ubiquitin Ligase RNF115 in Breast Cancer Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Exploring the Structural Requirements for Inhibition of the Ubiquitin E3 Ligase Breast Cancer Associated Protein 2 (BCA2) as a Treatment for Breast Cancer

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Skp2 Is a Promising Therapeutic Target in Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2012English

Caveolin-1: Oncogenic Role in Breast Cancer? Clues From Molecular Profiling.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

A Role for the E3 Ubiquitin Ligase NEDD4 in Keloid Pathogenesis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy